Advertisement

ELISPOT Techniques

  • Niannian Ji
  • Thomas G. ForsthuberEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1304)

Abstract

The enzyme-linked immunospot (ELISPOT) assay is a widely used method for enumerating antigen-specific cytokine-producing or antibody-secreting immune cells. It is one of the most effective immunological and diagnostic approaches to detect and quantify low-frequency cytokine- or antibody-producing cells in human and animal tissues, such as peripheral blood, lymph nodes, and spleen. Detection and quantification of specific cytokine-producing cells by the ELISPOT assay is based on the formation of visible spots at the site of cytokine release by the cells under investigation (e.g., T cells) using pairs of different capture and detection antibodies under optimized conditions.

Here we focus mainly on practical, optimized protocols for cytokine ELISPOT assays for detection of mouse and human cytokine-producing immune cells (e.g., peripheral blood mononuclear cells, PBMC), including suggestions for trouble-shooting and optimizing steps for problematic tissue samples.

Keywords

ELISPOT Antigen recall Cytokine Antibody Immune cells T cells PBMCs 

Notes

Acknowledgement

The authors would like to thank Dr. Neal Guentzel at the University of Texas at San Antonio for his valuable comments and suggestions during revision.

References

  1. 1.
    Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A (1983) A solid-phase enzyme-linked immunospot (Elispot) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65:109–121PubMedCrossRefGoogle Scholar
  2. 2.
    Russell MW, Czerkinsky C, Moldoveanu Z (1986) Detection and specificity of antibodies secreted by spleen cells in mice immunized with Streptococcus mutans. Infect Immun 53:317–323PubMedCentralPubMedGoogle Scholar
  3. 3.
    Tarkowski A, Czerkinsky C, Nilsson LA, Nygren H, Ouchterlony O (1984) Solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of IgG rheumatoid factor-secreting cells. J Immunol Methods 72:451–459PubMedCrossRefGoogle Scholar
  4. 4.
    Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O (1988) Reverse ELISPOT assay for clonal analysis of cytokine production. I Enumeration of gamma-interferon-secreting cells. J Immunol Methods 110:29–36PubMedCrossRefGoogle Scholar
  5. 5.
    Hutchings PR, Cambridge G, Tite JP, Meager T, Cooke A (1989) The detection and enumeration of cytokine-secreting cells in mice and man and the clinical application of these assays. J Immunol Methods 120:1–8PubMedCrossRefGoogle Scholar
  6. 6.
    Kabilan L, Andersson G, Lolli F, Ekre HP, Olsson T, Troye-Blomberg M (1990) Detection of intracellular expression and secretion of interferon-gamma at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol 20:1085–1089PubMedCrossRefGoogle Scholar
  7. 7.
    Kabilan L, Troye-Blomberg M, Andersson G, Riley EM, Ekre HP, Whittle HC, Perlmann P (1990) Number of cells from plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen. Infect Immun 58:2989–2994PubMedCentralPubMedGoogle Scholar
  8. 8.
    Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S (1991) Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 59:3021–3025PubMedCentralPubMedGoogle Scholar
  9. 9.
    elGhazali GE, Paulie S, Andersson G, Hansson Y, Holmquist G, Sun JB, Olsson T, Ekre HP, Troye-Blomberg M (1993) Number of interleukin-4- and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol 23:2740–2745PubMedCrossRefGoogle Scholar
  10. 10.
    Di Fabio S, Mbawuike IN, Kiyono H, Fujihashi K, Couch RB, McGhee JR (1994) Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells. Int Immunol 6:11–19PubMedCrossRefGoogle Scholar
  11. 11.
    Surcel HM, Troye-Blomberg M, Paulie S, Andersson G, Moreno C, Pasvol G, Ivanyi J (1994) Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 81:171–176PubMedCentralPubMedGoogle Scholar
  12. 12.
    Xu-Amano J, Jackson RJ, Fujihashi K, Kiyono H, Staats HF, McGhee JR (1994) Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine 12:903–911PubMedCrossRefGoogle Scholar
  13. 13.
    Lehmann PV, Zhang W (2012) Unique strengths of ELISPOT for T cell diagnostics. Methods Mol Biol 792:3–23PubMedCrossRefGoogle Scholar
  14. 14.
    Sambor, A., A. Garcia, M. Berrong, J. Pickeral, S. Brown, W. Rountree, A. Sanchez, J. Pollara, N. Frahm, S. Keinonen, G. H. Kijak, M. Roederer, G. Levine, M. P. D'Souza, M. Jaimes, R. Koup, T. Denny, J. Cox, and G. Ferrari. 2014. Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. J Immunol Methods.Google Scholar
  15. 15.
    Slota M, Lim JB, Dang Y, Disis ML (2011) ELISpot for measuring human immune responses to vaccines. Expert Rev Vaccines 10:299–306PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, Vives-Pi M, Powrie J, Tree T, Marchetti P, Huang GC, Gurzov EN, Pujol-Borrell R, Eizirik DL, Peakman M (2011) Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes 60:2112–2119PubMedCentralPubMedCrossRefGoogle Scholar
  17. 17.
    Moldovan IR, Rudick RA, Cotleur AC, Born SE, Lee JC, Karafa MT, Pelfrey CM (2005) Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing–remitting multiple sclerosis patients. Mult Scler 11:251–260PubMedCrossRefGoogle Scholar
  18. 18.
    Van Steendam K, De Ceuleneer M, Tilleman K, Elewaut D, De Keyser F, Deforce D (2013) Quantification of IFNgamma- and IL17-producing cells after stimulation with citrullinated proteins in healthy subjects and RA patients. Rheumatol Int 33:2661–2664PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Jansson A, Ernerudh J, Kvarnstrom M, Ekerfelt C, Vrethem M (2003) Elispot assay detection of cytokine secretion in multiple sclerosis patients treated with interferon-beta1a or glatiramer acetate compared with untreated patients. Mult Scler 9:440–445PubMedCrossRefGoogle Scholar
  20. 20.
    Pelfrey CM, Rudick RA, Cotleur AC, Lee JC, Tary-Lehmann M, Lehmann PV (2000) Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J Immunol 165:1641–1651PubMedCrossRefGoogle Scholar
  21. 21.
    Tanguay S, Killion JJ (1994) Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 13:259–263PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of BiologyThe University of Texas at San AntonioSan AntonioUSA

Personalised recommendations